Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00908336
Show Display Options
Rank Status Study
1 Unknown  Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Docetaxel and Erlotinib;   Drug: Erlotinib

Study has passed its completion date and status has not been verified in more than two years.